ADVI Perspectives: Opportunities for Private Equity Investors in Skilled Nursing Facilities
ADVI expert Farooq Tirmizi, vice president of mergers and acquisitions (M&A) advisory, talks about the headwinds and tailwinds for skilled nursing facilities (SNF) including the pandemic’s impact on SNF, Medicare Advantage penetration, increasing post-acute care utilization, and of course the surge in the aging senior population.
Part of what is highlighted is that the pandemic hit SNF capacity right before a surge in demand. SNF volumes nosedived during the pandemic, largely due to an increased preference for home health during the worst of the COVID-19 outbreaks in nursing homes.
Source: ADVI SAVEs analysis of data from the Medicare Part A Standard Analytical Files, and MedPAC.
Total SNF stay days in the Medicare population are expected to go up by 17.8% by 2030, of which the bulk of the increase is the result of the retirement of the Baby Boomers, with increased MA penetration causing only a small decrease in utilization.
Expert Commentary
Hear more from Farooq on the emerging opportunities for private equity investors interested in skilled nursing facilities.
Learn More
Stay ahead of the curve. Get in touch today to gain expert insights and the evolving healthcare landscape.
CEO insights
Related articles
Real analysis from people who’ve been there
The 2026 Rare Disease Reality
Orphan drugs now represent approximately 20 percent of total prescription spend, and over 52 percent of the cell and gene …
Marc Samuels, JD, MPH
February 26, 2026
FDA Proposes Down-Classification of Oncology Companion Diagnostics: A Q&A on Precision Medicine
The Food and Drug Administration (FDA) has announced a significant proposed change affecting oncology companion diagnostics (CDx) that could streamline …
2026 Life Sciences Forecast: AI, Next-Gen Cell & Gene Therapy, and Policy Disruption
In 2026, we expect the healthcare landscape to be defined by technology breakthroughs, market access disruption, and profound policy changes. …
Marc Samuels, JD, MPH
December 16, 2025
Delivering on CAR T-cell Therapy’s Promise: Policy Solutions for the Next Era of Cancer Care
CAR T-cell therapy offers a groundbreaking treatment option for patients with relapsed or refractory hematologic malignancies, yet access remains severely …
Alicia Silver, MPP
November 21, 2025
ADVI Instant: CMS Releases the Final Notice for TCET and 3 NCD Documents
On August 7, 2024, CMS released the final notice for the Transitional Coverage for Emerging Technologies (TCET) pathway (link) and …
Alicia Silver, MPP
August 16, 2024
Biggest Barriers to Market Access in the Evolving Healthcare Landscape
As healthcare evolves, so does market access. From new team structures to mergers and acquisitions, pharma and device manufacturers must …
ADVI Instant: FDA Files Final Rule on Regulation of Laboratory Developed Tests
On April 29, 2024, the Food and Drug Administration (FDA) filed a final rule (link) that explicitly labels laboratory developed …
What are We Excited to Bring to ADVI Clients in 2024?
As the first quarter of 2024 is coming to a close, we wrap up our 2024 ADVI Health Predictions series …
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.